These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26099177)

  • 1. Bromodomain inhibitors regulate the C9ORF72 locus in ALS.
    Zeier Z; Esanov R; Belle KC; Volmar CH; Johnstone AL; Halley P; DeRosa BA; Khoury N; van Blitterswijk M; Rademakers R; Albert J; Brothers SP; Wuu J; Dykxhoorn DM; Benatar M; Wahlestedt C
    Exp Neurol; 2015 Sep; 271():241-50. PubMed ID: 26099177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.
    Liu EY; Russ J; Wu K; Neal D; Suh E; McNally AG; Irwin DJ; Van Deerlin VM; Lee EB
    Acta Neuropathol; 2014 Oct; 128(4):525-41. PubMed ID: 24806409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions.
    Cooper-Knock J; Walsh MJ; Higginbottom A; Robin Highley J; Dickman MJ; Edbauer D; Ince PG; Wharton SB; Wilson SA; Kirby J; Hautbergue GM; Shaw PJ
    Brain; 2014 Jul; 137(Pt 7):2040-51. PubMed ID: 24866055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide-repeat proteins expression in cells.
    Bauer PO
    Neurosci Lett; 2016 Jan; 612():204-209. PubMed ID: 26690922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
    Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells.
    Esanov R; Belle KC; van Blitterswijk M; Belzil VV; Rademakers R; Dickson DW; Petrucelli L; Boylan KB; Dykxhoorn DM; Wuu J; Benatar M; Wahlestedt C; Zeier Z
    Exp Neurol; 2016 Mar; 277():171-177. PubMed ID: 26746986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
    Gitler AD; Tsuiji H
    Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis.
    Konopka A; Atkin JD
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders.
    Mis MSC; Brajkovic S; Tafuri F; Bresolin N; Comi GP; Corti S
    Mol Neurobiol; 2017 Aug; 54(6):4466-4476. PubMed ID: 27349438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
    Todd TW; Petrucelli L
    J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.
    Belzil VV; Bauer PO; Prudencio M; Gendron TF; Stetler CT; Yan IK; Pregent L; Daughrity L; Baker MC; Rademakers R; Boylan K; Patel TC; Dickson DW; Petrucelli L
    Acta Neuropathol; 2013 Dec; 126(6):895-905. PubMed ID: 24166615
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lynch E; Semrad T; Belsito VS; FitzGibbons C; Reilly M; Hayakawa K; Suzuki M
    Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31439573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
    Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C
    Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers.
    DeJesus-Hernandez M; Finch NA; Wang X; Gendron TF; Bieniek KF; Heckman MG; Vasilevich A; Murray ME; Rousseau L; Weesner R; Lucido A; Parsons M; Chew J; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; de Boer J; Asmann YW; Petrucelli L; Boylan KB; Dickson DW; van Blitterswijk M; Rademakers R
    Acta Neuropathol; 2017 Aug; 134(2):255-269. PubMed ID: 28508101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration.
    Ohki Y; Wenninger-Weinzierl A; Hruscha A; Asakawa K; Kawakami K; Haass C; Edbauer D; Schmid B
    Mol Neurodegener; 2017 Jan; 12(1):6. PubMed ID: 28088213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of normal
    Peverelli S; Brusati A; Casiraghi V; Sorce MN; Invernizzi S; Santangelo S; Morelli C; Verde F; Silani V; Ticozzi N; Ratti A
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):207-210. PubMed ID: 38099605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS.
    Rossi S; Serrano A; Gerbino V; Giorgi A; Di Francesco L; Nencini M; Bozzo F; Schininà ME; Bagni C; Cestra G; Carrì MT; Achsel T; Cozzolino M
    J Cell Sci; 2015 May; 128(9):1787-99. PubMed ID: 25788698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.